1/1/2026, 8:11:02 pm

Aurobindo Pharma buys Khandelwal Labs' non-oncology business

Aurobindo Pharma's wholly-owned subsidiary Auro Pharma Ltd acquired Khandelwal Laboratories' branded non-oncology prescription formulations business for ₹3,250 million. The business includes 23 brands, 67 SKUs, and 9 pipeline products, employing 470 field staff with a ₹1,135.3 million turnover in FY2024-25 and ₹289.9 million EBITDA.